Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
Michael Goggins(Johns Hopkins University), Marco J. Bruno(Erasmus MC), Aimee L. Lucas(Icahn School of Medicine at Mount Sinai), Elliot K. Fishman(Johns Hopkins University), Anne Marie Lennon(University of Pittsburgh Medical Center), Anil K. Rustgi(Columbia University Irving Medical Center), Diane M. Simeone(UC San Diego Health System), Fay Kastrinos(Columbia University Irving Medical Center), Elena M. Stoffel(University of Michigan), Randall E. Brand(University of Pittsburgh), Marcia Irene Canto(Johns Hopkins University), Djuna L. Cahen(Erasmus MC), Marco Del Chiaro(University of Colorado Hospital), Kasper A. Overbeek(Erasmus MC), Paul Fockens(Amsterdam University Medical Centers), Alfredo Carrato(Hospital General Universitario de Elche), Jeanin E. van Hooft(Leiden University Medical Center), Sapna Syngal(Brigham and Women's Hospital), Thomas M. Gress(Universitätsklinikum Gießen und Marburg), Walter G. Park(Columbia University Irving Medical Center), Detlef K. Bartsch(Philipps University of Marburg), James J. Farrell(Yale University), Claudio Bassi(University of Verona), Ralph H. Hruban(Johns Hopkins University), A S Klein(Johns Hopkins University), Hans F. A. Vasen(Leiden University Medical Center)
Cited by 620
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Identification of Pancreatic Cancer Stem Cells
|Cancer Research|2007|3.4k